Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?

PURPOSE: Conversion therapy gives some patients with initially unresectable hepatocellular carcinoma (HCC) access to surgery. The purpose of this study was to evaluate the safety and efficacy of hepatectomy after conversion therapy and how it differed from those who undergoing direct hepatectomy. PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Laihui, He, Yongzhu, Zhu, Guoqing, Xiao, Yongqiang, Song, Shengjiang, Ge, Xian, Wang, Tao, Xie, Jin, Deng, Wei, Hu, Zhigao, Shan, Renfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792109/
https://www.ncbi.nlm.nih.gov/pubmed/36578526
http://dx.doi.org/10.2147/JHC.S388965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792109/
https://www.ncbi.nlm.nih.gov/pubmed/36578526
http://dx.doi.org/10.2147/JHC.S388965

Ejemplares similares